Europlasma S.A.
ALEUP.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 59.35 | 0.64 | 0.67 | 0.00 |
| FCF Yield | -0.01% | -1.31% | -1.26% | 0.00% |
| EV / EBITDA | -27,043.37 | -245.40 | -200.54 | -0.54 |
| Quality | ||||
| ROIC | -144.34% | -100.26% | -51.20% | -56.63% |
| Gross Margin | -48.51% | -113.02% | -94.68% | -97.77% |
| Cash Conversion Ratio | 0.75 | 0.71 | 0.66 | 1.45 |
| Growth | ||||
| Revenue 3-Year CAGR | 42.99% | 16.26% | 56.41% | 45.96% |
| Free Cash Flow Growth | -6.70% | 9.06% | 43.67% | -38.84% |
| Safety | ||||
| Net Debt / EBITDA | -3.43 | -2.69 | -1.12 | -0.54 |
| Interest Coverage | -8.44 | -5.58 | -2.89 | -1.69 |
| Efficiency | ||||
| Inventory Turnover | 3.53 | 4.17 | 4.27 | 6.45 |
| Cash Conversion Cycle | 181.64 | 131.14 | 221.00 | 212.03 |